PedAM
Pediatric Disease Annotations & Medicines
| Disease | vasculitis |
| Phenotype | C0004096|asthma |
| Sentences | 10 |
| PubMedID- 23303591 | The churg-strauss syndrome (css), first described in 1951 and characterised by eosinophilic inflammation and necrotising vasculitis in patients with asthma can in principle affect any organ. |
| PubMedID- 20039171 | Churg-strauss syndrome (scs) is a systemic vasculitis associated with asthma and eosinophilia. |
| PubMedID- 24286362 | In egpa small-vessel vasculitis is associated with eosinophilia and asthma [1]. |
| PubMedID- 21325353 | Introduction: churg-strauss syndrome (css) is a small vessel systemic vasculitis associated with asthma and eosinophilia that causes glomerulonephritis (gn) in approximately 25% of patients. |
| PubMedID- 25703656 | Background: eosinophilic granulomatosis with polyangiitis (egpa) is a rare systemic small-vessel vasculitis associated with asthma, eosinophilia, and necrotizing vasculitis. |
| PubMedID- 24574837 | Background/aims: churg-strauss syndrome (css) is a rare systemic necrotizing small-vessel vasculitis, with accompanying bronchial asthma, eosinophilia, and eosinophilic infiltration of various tissues. |
| PubMedID- 23330816 | Eosinophilic granulomatosis with polyangiitis (churg-strauss, egpa) is a systemic small-vessel vasculitis associated with asthma and eosinophilia. |
| PubMedID- 26029516 | Eosinophilic granulomatosis with polyangiitis (egpa) is a systemic small vessel vasculitis associated with asthma and eosinophilia. |
| PubMedID- 23544278 | Css is a rare small-vessel vasculitis that is associated with asthma, granulomatous inflammation, peripheral/tissue eosinophilia and a positive anca status (in approximately 40% of patients).13-16) although this disease’s hallmarks are now well-known, its pathophysiological mechanisms remain to be fully understood. |
| PubMedID- 24048112 | Churg-strauss syndrome (css) is a rare small-vessel vasculitis typically associated with adult-onset asthma, peripheral and tissue hypereosinophilia, migratory pulmonary infiltrates, upper respiratory tract symptoms, and clinical evidence of systemic vasculitis. |
Page: 1